Structural mechanisms of costimulation

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Nature Immunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/ni0502-427PMID 11976720
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Distinct Role of CD80 and CD86 in the Regulation of the Activation of B Cell and B Cell Lymphoma*

  2002cited by this paper
• Expression, refolding, purification, molecular characterization, crystallization, and preliminary X-ray analysis of the receptor binding domain of human B7-2.

  2002cited by this paper
• Immunology. The immunological synapse--a multitasking system.

  2002cited by this paper
• The Immunological Synapse--a Multitasking System

  2002cited by this paper
• T Cell Receptor Signaling Precedes Immunological Synapse Formation

  2002cited by this paper
• Developmentally Regulated Glycosylation of the CD8αβ Coreceptor Stalk Modulates Ligand Binding

  2001cited by this paper
• Structural basis for co-stimulation by the human CTLA-4/B7-2 complex

  2001cited by this paper
• Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses

  2001cited by this paper
• Crystal structure of an Eph receptor–ephrin complex

  2001cited by this paper
• Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation

  2001cited by this paper
• The immunological synapse and CD28-CD80 interactions

  2001cited by this paper
• Physiological Regulation of the Immunological Synapse by Agrin

  2001cited by this paper
• CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy.

  2001cited by this paper
• PD-L2 is a second ligand for PD-1 and inhibits T cell activation

  2001cited by this paper
• Developmentally regulated glycosylation of the CD8alphabeta coreceptor stalk modulates ligand binding.

  2001cited by this paper
• The immunological synapse.

  2001cited by this paper
• Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice.

  2001cited by this paper
• CTLA-4 regulates induction of anergy in vivo.

  2001cited by this paper
• B7-Dc, a New Dendritic Cell Molecule with Potent Costimulatory Properties for T Cells

  2001cited by this paper
• Functional Responses and Costimulator Dependence of Memory CD4+ T Cells1

  2000cited by this paper
• The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity

  2000cited by this paper
• Janus kinase 2 is associated with a box 1‐like motif and phosphorylates a critical tyrosine residue in the cytoplasmic region of cytotoxic T lymphocyte associated molecule‐4

  2000cited by this paper
• Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization.

  2000cited by this paper
• A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling.

  2000cited by this paper
• The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A.

  2000cited by this paper
• Structure of murine CTLA-4 and its role in modulating T cell responsiveness.

  2000cited by this paper
• Structure and dimerization of a soluble form of B7-1.

  2000cited by this paper
• Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation

  2000cited by this paper
• Protein tyrosine kinase structure and function.

  2000cited by this paper
• Signalling through the high-affinity IgE receptor FcεRI

  1999cited by this paper
• Dependence of T Cell Antigen Recognition on the Dimensions of an Accessory Receptor–Ligand Complex

  1999cited by this paper
• T-cell co-stimulation through B7RP-1 and ICOS

  1999cited by this paper
• ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28

  1999cited by this paper
• Structure of a heterophilic adhesion complex between the human CD2 and CD58 (LFA-3) counterreceptors.

  1999cited by this paper
• Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5.

  1999cited by this paper
• Structure of the TRAIL–DR5 complex reveals mechanisms conferring specificity in apoptotic initiation

  1999cited by this paper
• Signalling through the high-affinity IgE receptor Fc epsilonRI.

  1999cited by this paper
• Tumor necrosis factor receptor and Fas signaling mechanisms.

  1999cited by this paper
• Quaternary structure of the insulin-insulin receptor complex.

  1999cited by this paper
• Identification and Characterization of a Ligand-independent Oligomerization Domain in the Extracellular Region of the CD95 Death Receptor*

  1999cited by this paper
• B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha.

  1999cited by this paper
• Erythropoietin receptor activation by a ligand-induced conformation change.

  1999cited by this paper
• Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor.

  1999cited by this paper
• Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation.

  1999cited by this paper
• Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production.

  1998cited by this paper
• Molecular basis of T cell inactivation by CTLA-4.

  1998cited by this paper
• A receptor/cytoskeletal movement triggered by costimulation during T cell activation.

  1998cited by this paper
• Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

  1998cited by this paper
• Interaction of CTLA-4 with AP50, a clathrin-coated pit adaptor protein.

  1997cited by this paper
• Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28

  1997cited by this paper
• Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor.

  1997cited by this paper
• CD86 (B7-2) on Human B Cells

  1997cited by this paper
• CD86 (B7-2) on human B cells. A functional role in proliferation and selective differentiation into IgE- and IgG4-producing cells.

  1997cited by this paper
• Structure of the complex between human T-cell receptor, viral peptide and HLA-A2

  1996cited by this paper
• Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2).

  1996cited by this paper
• CD28/B7 system of T cell costimulation.

  1996cited by this paper
• Regulation of T Cell Receptor Signaling by Tyrosine Phosphatase SYP Association with CTLA-4

  1996cited by this paper
• Transmembrane signaling through CD80 (B7-1) induces growth arrest and cell spreading of human B lymphocytes accompanied by protein tyrosine phosphorylation.

  1996cited by this paper
• An αβ T Cell Receptor Structure at 2.5 Å and Its Orientation in the TCR-MHC Complex

  1996cited by this paper
• Both Extracellular Immunoglobin-like Domains of CD80 Contain Residues Critical for Binding T Cell Surface Receptors CTLA-4 and CD28 (*)

  1995cited by this paper
• Dali: a network tool for protein structure comparison.

  1995cited by this paper
• CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells

  1995cited by this paper
• Structural basis of cell-cell adhesion by cadherins

  1995cited by this paper
• Immunoglobulin fold characteristics of B7–1 (CD80) and B7–2 (CD86)

  1994cited by this paper
• Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1

  1994cited by this paper
• CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.

  1994cited by this paper
• SETOR: hardware-lighted three-dimensional solid model representations of macromolecules.

  1993cited by this paper
• Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.

  1993cited by this paper
• Characterization of CTLA-4 structure and expression on human T cells.

  1993cited by this paper
• Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation.

  1993cited by this paper
• Crystal structure of a soluble form of the human T cell coreceptor CD8 at 2.6 A resolution.

  1992cited by this paper
• Induced expression of PD‐1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.

  1992cited by this paper
• Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule.

  1991cited by this paper
• Protein multiple sequence alignment and flexible pattern matching.

  1990cited by this paper
• B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells.

  1989cited by this paper
• The immunoglobulin superfamily--domains for cell surface recognition.

  1988cited by this paper
• A 44 kilodalton cell surface homodimer regulates interleukin 2 production by activated human T lymphocytes.

  1986cited by this paper

• Antagonism of CD28 blocks allergic responses in the ovalbumin-induced asthmatic model mice.

  2025cites this paper
• Unleashing the Power of immune Checkpoints: A new strategy for enhancing Treg cells depletion to boost antitumor immunity.

  2025cites this paper
• Preclinical models of immune checkpoint inhibitors-related interstitial pneumonia for anti-PD1 tumor immunotherapy.

  2025cites this paper
• Molecular and structural basis of TIGIT: Nectin-4 interaction, a recently discovered pathway crucial for cancer immunotherapy.

  2023cites this paper
• A systematic review and meta-analysis of immune checkpoint therapy in relapsed or refractory non-Hodgkin lymphoma; a friend or foe?

  2023cites this paper
• Role of TNFSF9 bidirectional signal transduction in antitumor immunotherapy.

  2022cites this paper
• The engineered CD80 variant fusion therapeutic davoceticept combines checkpoint antagonism with conditional CD28 costimulation for anti-tumor immunity

  2022cites this paper
• Delivery of antigen to porcine dendritic cells by fusing antigen with porcine dendritic cells targeting peptide

  2022cites this paper
• Programmable allosteric DNA regulations for molecular networks and nanomachines

  2022cites this paper
• Targeted Therapy of B7 Family Checkpoints as an Innovative Approach to Overcome Cancer Therapy Resistance: A Review from Chemotherapy to Immunotherapy

  2022cites this paper
• Innate and adaptive immunity in cancer

  2022cites this paper
• TNF-α inhibitor ameliorates immune-related arthritis and pneumonitis in humanized mice

  2022cites this paper
• Topological and Structural Plasticity of the Single Ig Fold and the Double Ig Fold Present in CD19

  2021cites this paper
• The application of immune checkpoint blockade in breast cancer and the emerging role of nanoparticle.

  2021cites this paper
• Discovery of receptor‐ligand interfaces in the immunoglobulin superfamily

  2020cites this paper
• An update of knowledge on PD-L1 in head and neck cancers: Physiologic, prognostic and therapeutic perspectives.

  2020cites this paper
• Structural Insights into N-Terminal IgV Domain of BTNL2, a T Cell Inhibitory Molecule, Suggests a Non-canonical Binding Interface for its Putative Receptors.

  2020cites this paper
• Revisiting the PD-1 pathway

  2020cites this paper
• Folded or Degraded in Endoplasmic Reticulum.

  2020cites this paper
• Components and Design of Chimeric Antigen Receptors

  2020cites this paper
• The CD28-B7 Family of Co-signaling Molecules.

  2019cites this paper
• Immune Checkpoints of the B7 Family. Part 1. General Characteristics and First Representatives: B7-1, B7-2, B7-H1, B7-H2, and B7-DC

  2019cites this paper
• Immune Checkpoints of the B7 Family. Part 2. Representatives of the B7 Family B7-H3, B7-H4, B7-H5, B7-H6, B7-H7, and ILDR2 and Their Receptors

  2019cites this paper
• The Immunology of Transplantation

  2019cites this paper
• HIV Interferes with the Dendritic Cell–T Cell Axis of Macrophage Activation by Shifting Mycobacterium tuberculosis–Specific CD4 T Cells into a Dysfunctional Phenotype

  2018cites this paper
• Molecular Mechanisms of T Cells Activation by Dendritic Cells in Autoimmune Diseases

  2018cites this paper
• The promise and challenges of immune agonist antibody development in cancer

  2018cites this paper
• Multiple effects of CD40–CD40L axis in immunity against infection and cancer

  2018cites this paper
• Identification of another primordial CD80/86 molecule in rainbow trout: Insights into the origin and evolution of CD80 and CD86 in vertebrates

  2018cites this paper
• Conservation of structural and interactional features of CD28 and CD80/86 molecules from Nile tilapia (Oreochromis niloticus)

  2018cites this paper
• Cancer-associated oxidoreductase ERO1-α promotes immune escape through up-regulation of PD-L1 in human breast cancer

  2017cites this paper
• Inflammatory cytokines compromise programmed cell death‐1 (PD‐1)‐mediated T cell suppression in inflammatory arthritis through up‐regulation of soluble PD‐1

  2017cites this paper
• OX40: Structure and function - What questions remain?

  2017cites this paper
• CD28 Costimulation: From Mechanism to Therapy.

  2016cites this paper
• Analysis of Mitogen-Activated Protein Kinases in Bone and Cartilage of Patients with Rheumatoid Arthritis Treated with Abatacept

  2016cites this paper
• Regulation of Immunity by Butyrophilins.

  2016cites this paper
• Cancer immunotherapy via nucleic acid aptamers.

  2015cites this paper
• Immunogenetics of Disease-Causing Inflammation in Sarcoidosis

  2015cites this paper
• Immunotherapy for lung cancer: for whom the bell tolls?

  2015cites this paper
• Role of SLAM family receptors and specific adapter SAP in innate-like lymphocytes.

  2014cites this paper
• B Cell Central Tolerance: Controlling Self-Reactive B Cells in the Bone Marrow

  2014cites this paper
• CTLA4-IgG ameliorates homocysteine-accelerated atherosclerosis by inhibiting T-cell overactivation in apoE(-/-) mice.

  2013cites this paper
• Étude du mécanisme moléculaire d'incorporation de la molécule de l'hôte ICAM-1 par le VIH-1

  2013cites this paper
• Targeting Costimulatory Molecules to Improve Antitumor Immunity

  2012influential citation
• A fiber-modified adenoviral vector interacts with immunoevasion molecules of the B7 family at the surface of murine leukemia cells derived from dormant tumors

  2011influential citation
• Cis–trans interactions of cell surface receptors: biological roles and structural basis

  2011cites this paper
• Harnessing Dendritic Cells for Tumor Antigen Presentation

  2011cites this paper
• Dynamic tuning of T cell receptor specificity by co-receptors and costimulation

  2011cites this paper
• Definitive evidence that a single N-glycan among three glycans on inducible costimulator is required for proper protein trafficking and ligand binding.

  2010cites this paper
• a Primitive Teleost Fish ), Oncorhynchus mykiss from Rainbow Trout ( Features in a Primordial CD80/86 Molecule Conservation of Structural and Functional

  2009influential citation
• CD167 Acts as a Novel Costimulatory Receptor in T-Cell Activation

  2009cites this paper
• Conservation of Structural and Functional Features in a Primordial CD80/86 Molecule from Rainbow Trout (Oncorhynchus mykiss), a Primitive Teleost Fish12

  2009influential citation
• Sequence, structure, function, immunity: structural genomics of costimulation

  2009cites this paper
• Distinct conformations of Ly49 natural killer cell receptors mediate MHC class I recognition in trans and cis.

  2009cites this paper
• CTLA‐4: a key regulatory point in the control of autoimmune disease

  2008cites this paper
• Mapping of the ICOS binding surface of murine B7h using an unbiased, cellular library of B7h mutants created by cyclical packaging rescue.

  2008cites this paper
• The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors

  2008cites this paper
• Abatacept modulates human dendritic cell-stimulated T-cell proliferation and effector function independent of IDO induction.

  2008cites this paper
• The PD-1 / PD-L 1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors

  2008cites this paper
• CTLA-4 directly inhibits osteoclast formation

  2008cites this paper
• Characterization of oligomers induced by inverse agonists of CTLA-4.

  2008cites this paper
• Immune intervention with monoclonal antibodies targeting CD152 (CTLA-4) for autoimmune and malignant diseases.

  2008cites this paper
• Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2

  2008cites this paper
• Chapter 2 – Immunology of Graft Rejection

  2008cites this paper
• Cytotoxic T-Lymphocyte–Associated Antigen-4

  2007cites this paper
• Specific and high-affinity binding of tetramerized PD-L1 extracellular domain to PD-1-expressing cells: possible application to enhance T cell function.

  2007cites this paper
• Cytotoxic T-Lymphocyte–Associated Antigen-4

  2007cites this paper
• Suppression of immune responses in collagen-induced arthritis by a rationally designed CD80-binding peptide agent.

  2007cites this paper
• Site-directed in vitro immunization leads to a complete human monoclonal IgG4λ that binds specifically to the CDR2 region of CTLA-4 (CD152) without interfering the engagement of natural ligands

  2007cites this paper
• Targeting Costimulatory Pathways for Tumor Immunotherapy

  2007cites this paper
• Master switches of T-cell activation and differentiation

  2007cites this paper
• Agrin is involved in lymphocytes activation that is mediated by alpha-dystroglycan.

  2006cites this paper
• B7.1/NHS76: A New Costimulator Fusion Protein for the Immunotherapy of Solid Tumors

  2006cites this paper
• CTLA‐4 lacking the cytoplasmic domain costimulates IL‐2 production in T‐cell hybridomas

  2006cites this paper
• CD137-mediated immunotherapy for allergic asthma.

  2006cites this paper
• The Cytoplasmic Domain of Fas Ligand Costimulates TCR Signals1

  2006cites this paper
• Agrin is involved in lymphocytes activation that is mediated by α‐dystroglycan

  2006cites this paper
• This information is current as Costimulates TCR Signals The Cytoplasmic Domain of Fas Ligand

  2006cites this paper
• The crystal structure of the costimulatory OX40-OX40L complex.

  2006cites this paper
• The dendritic cell-T cell synapse as a determinant of autoimmune pathogenesis.

  2006cites this paper
• A molecular perspective of CTLA-4 function.

  2006cites this paper
• Employing the immunological synapse in AML: development of leukemic dendritic cells for active specific immunization.

  2005cites this paper
• Biological Relevance for T Cell Inactivation Dimer-Based Lattice Formation and Its Hierarchical Regulation of CTLA-4

  2005cites this paper
• A mutant B7-1/Ig fusion protein that selectively binds to CTLA-4 ameliorates anti-tumor DNA vaccination and counters regulatory T cell activity.

  2005cites this paper
• Immunomodulatory peptides from IgSF proteins: a review.

  2005cites this paper
• A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator.

  2005cites this paper
• Hierarchical Regulation of CTLA-4 Dimer-Based Lattice Formation and Its Biological Relevance for T Cell Inactivation1

  2005cites this paper
• Interactions at the Dendritic Cell / T-Cell Interface Define the Balance between Immunity and Tolerance

  2005cites this paper
• The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation.

  2005cites this paper
• Combination B 7-Fc Fusion ProteinTreatment and Treg Cell

  2005cites this paper
• ICAM-1 co-stimulates target cells to facilitate antigen presentation.

  2005cites this paper
• BTLA, a new inhibitory B7 family receptor with a TNFR family ligand.

  2005cites this paper
• Combination B7-Fc Fusion Protein Treatment and Treg Cell Depletion Therapy

  2005cites this paper
• Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunity

  2004cites this paper
• Aktivierung von T-Zellen durch Glykoprotein 96-gereifte Dendritische Zellen

  2004cites this paper
• The paradox of T cell–mediated antitumor immunity in spite of poor clinical outcome in human melanoma

  2004cites this paper
• Association between CTLA-4 +49 A/G polymorphism and type 1B diabetes in Japanese population

  2004cites this paper
• Cellular Constituents of the Skin Immune System

  2004cites this paper
• Conversion of CTLA-4 from Inhibitor to Activator of T Cells with a Bispecific Tandem Single-Chain Fv Ligand1

  2004cites this paper
• Pathogenic antibodies to coagulation factors. Part one: Factor VIII and Factor IX

  2004cites this paper